Unexpected Intraoperative Life Threatening Haemorrhage: National Clinical Guideline No. 29: Annex A: Clinical Guidelines for the Management of Massive Haemorrhage – A systematic review.
dc.contributor.author | National Clinical Effectiveness Committee (NCEC) | |
dc.contributor.author | National Patient Safety Office | |
dc.contributor.author | Health Service Executive | |
dc.date.accessioned | 2022-05-26T15:15:09Z | |
dc.date.available | 2022-05-26T15:15:09Z | |
dc.date.issued | 2020-06 | |
dc.identifier.uri | http://hdl.handle.net/10147/632003 | |
dc.description | In 2016, the Department of Health requested that the Health Research Board (HRB) fund an evidence synthesis service called HRB-CICER (Collaboration in Ireland for Clinical Effectiveness Reviews) to support the activities of the Ministerial appointed National Clinical Effectiveness Committee (NCEC). Following a competitive process, the Health Information and Quality Authority (HIQA) was awarded the contract for the five-year period from 2017 to 2022. The HRB-CICER team comprises a dedicated multidisciplinary research team supported by staff from the Health Technology Assessment (HTA) team in HIQA and the HRB Centre for Primary Care Research at the Royal College of Surgeons in Ireland (RCSI), as well as national and international clinical and methodological experts. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Department of Health | en_US |
dc.relation.ispartofseries | National Clinical Guideline No. 29 | en_US |
dc.subject | HAEMORRHAGE | en_US |
dc.subject | SURGERY | en_US |
dc.subject | RISK | en_US |
dc.title | Unexpected Intraoperative Life Threatening Haemorrhage: National Clinical Guideline No. 29: Annex A: Clinical Guidelines for the Management of Massive Haemorrhage – A systematic review. | en_US |
dc.type | Other | en_US |
refterms.dateFOA | 2022-05-26T15:15:09Z |